Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignancy in Crohn's disease

D Bernstein1, A Rogers

  • 1Division of Hepatology, University of Miami School of Medicine, Florida.

The American Journal of Gastroenterology
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strengthening incident learning in radiotherapy practice: insights from the MARLIN study.

Clinical and translational radiation oncology·2026
Same author

Community art for violence prevention in Africa: a review of the literature.

Public health·2026
Same author

Defining Standard Data Reporting in Pelvic Exenterations for Non-Rectal Cancers: A Systematic Review of Current Data Reporting.

Cancers·2025
Same author

Computational analysis of therapeutic potential for simplified Piper. spp- derived medicinal mixtures in anxiety, sleep, pain and seizure.

bioRxiv : the preprint server for biology·2025
Same author

In-hospital management of the airway in trauma.

BJA education·2024
Same author

Effectiveness of peer-delivered sleep health education and social support in increasing OSA evaluation among at-risk blacks.

Journal of sleep research·2024
Same journal

Calendar of Courses, Symposiums and Conferences.

The American journal of gastroenterology·2026
Same journal

Molecular Nonendoscopic Tests for the Early Detection of Esophageal Squamous Carcinoma and High-Grade Dysplasia: Promising Progress.

The American journal of gastroenterology·2026
Same journal

ACG Clinical Guideline: Colonic Diverticulitis.

The American journal of gastroenterology·2026
Same journal

Continuing Medical Education Questions: July 2026.

The American journal of gastroenterology·2026
Same journal

Continuing Medical Education Questions: July 2026.

The American journal of gastroenterology·2026
Same journal

2026 CME Information.

The American journal of gastroenterology·2026
See all related articles

The risk of malignancy, particularly small bowel adenocarcinoma and colorectal carcinoma, is elevated in Crohn's disease patients. Key risk factors include disease duration, sex, and specific disease complications.

Area of Science:

  • Gastroenterology
  • Oncology

Background:

  • Malignancy risk in Crohn's disease (CD) is less defined than in ulcerative colitis.
  • The association between CD and gastrointestinal (GI) cancers requires further clarification.

Purpose of the Study:

  • To review the current literature on the association between Crohn's disease and various malignancies.
  • To define the magnitude of cancer risk in CD patients.

Main Methods:

  • Review of population-based, case-control, referral center studies, and case reports.
  • Focus on literature concerning small bowel adenocarcinoma and colorectal carcinoma in CD.

Main Results:

  • Increased risk of small bowel adenocarcinoma in CD patients compared to the general population, though magnitude is unclear.

Related Experiment Videos

  • Risk factors for small bowel carcinoma in CD include male sex, disease duration, fistulas, and excluded bowel loops.
  • Crohn's colitis is linked to increased colorectal carcinoma risk, especially with long-standing disease, strictures, fistulas, and right-sided colonic disease.
  • Conclusions:

    • While secondary GI cancers are rare in CD, specific malignancies like small bowel adenocarcinoma and colorectal carcinoma present an elevated risk.
    • Identifying risk factors is crucial for monitoring and managing cancer risk in Crohn's disease patients.